ELLIOT M EPNER
Medical Practice in Harrisburg, PA
License number
Pennsylvania MD435858
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Harrisburg, PA 17111
Personal information
See more information about ELLIOT M EPNER at radaris.comName
Address
Phone
1000 Willoughby Rd, Harrisburg, PA 17111
1000 Willoughby Rd, Harrisburg, PA 17111
Professional information
See more information about ELLIOT M EPNER at trustoria.com
Professor Of Medicine At Penn State Med Ctr
Professor Of Medicine At Penn State Med Ctr
Position:
Professor of Medicine at Penn State Med Ctr
Location:
Harrisburg, Pennsylvania Area
Industry:
Medical Practice
Work:
Penn State Med Ctr
since Oct 2008
-
Professor of Medicine
OHSU
2003 - 2008
-
Associate Professor of Medicine
University of Arizona
1998 - 2003
-
Assistant Professor of Medicine
Fred Hutchinson Cancer Research Center
1986 - 1998
-
Fellow/Assistant Member
fred huchinson cancer center
1986 - 1989
-
fellow
Memorial Sloan-Kettering Cancer Center
1981 - 1983
-
student
Columbia University
1976 - 1983
-
MD PhD student
Education:
Columbia University College of Physicians and Surgeons 1976 - 1983
MDPhD, Genetics Wesleyan University 1972 - 1976
AB, Biology
MDPhD, Genetics Wesleyan University 1972 - 1976
AB, Biology
Languages:
spanish
Pharmaceutical Composition Containing A Hypomethylating Agent And A Histone Deacetylase Inhibitor
Pharmaceutical Composition Containing A Hypomethylating Agent And A Histone Deacetylase Inhibitor
US Patent:
8491927, Jul 23, 2013
Filed:
Apr 29, 2010
Appl. No.:
12/769913
Inventors:
Elliot M. Epner - Harrisburg PA, US
Luke M. Vaughan - Del Mar CA, US
Luke M. Vaughan - Del Mar CA, US
Assignee:
Nimble Epitech, LLC - Del Mar CA
International Classification:
A61K 9/70, A61F 13/00, A01N 43/04
US Classification:
424449, 514 46
Abstract:
A pharmaceutical composition for induction therapy which has a hypomethylating agent and a histone deacetylase inhibitor (“HDAC inhibitor”); wherein the hypomethylating agent is a DNA and histone methylation inhibitor such as cladribine and the HDAC inhibitor is, for example, entinostat, panobinostat, vorinostat, and/or romedepsin; further wherein the hypomethylating agent and the HDAC inhibitor are combined in formulations for various administrations including e. g. , a continuous delivery system such as a transdermal patch of at least one reservoir or a plurality of reservoirs, oral, a fixed-dose oral combination, intravenous, and combinations thereof. This pharmaceutical composition for induction therapy is used with a monoclonal antibody in the treatment of various cancers, sarcomas, and other malignancies.
Pharmaceutical Composition Containing A Hypomethylating Agent And A Histone Deacetylase Inhibitor
Pharmaceutical Composition Containing A Hypomethylating Agent And A Histone Deacetylase Inhibitor
US Patent:
2012031, Dec 6, 2012
Filed:
Apr 30, 2010
Appl. No.:
13/513327
Inventors:
Elliot M. Epner - Harrisburg PA, US
Luke M. Vaughan - Del Mar CA, US
Luke M. Vaughan - Del Mar CA, US
Assignee:
NIMBLE EPITECH, LLC - Del Mar CA
International Classification:
A61K 31/7088, A61M 35/00
US Classification:
604290, 514 44 R, 604304
Abstract:
A pharmaceutical composition for induction therapy which has a hypomethylating agent and a histone deacetylase inhibitor (“HDAC inhibitor”); wherein the hypomethylating agent is a DNA and histone methylation inhibitor such as cladribine and the HDAC inhibitor is, for example, entinostat, panobinostat, vorinostat, and/or romedepsin; further wherein the hypomethylating agent and the HDAC inhibitor are combined in formulations for various administrations including e.g., a continuous delivery system such as a transdermal patch of at least one reservoir or a plurality of reservoirs, oral, a fixed-dose oral combination, intravenous, and combinations thereof. This pharmaceutical composition for induction therapy is used with a monoclonal antibody in the treatment of various cancers, sarcomas, and other malignancies.